Acute coronary syndrome (ACS) covers a range of conditions, including myocardial infarction. Though mortality rates are falling globally for ACS,1 it remains a major cause of mortality among people over 35 years of age – accounting for a third of all mortality cases among this group.1
In addition, acute myocardial infarction necessitate quick action. Thus, there’s an ever-present need to optimise diagnostics methods and speed up triage and identification of the most appropriate course of action, if we are to drive a reduction in this high mortality rate.
In this fascinating webinar, prolific cardiology researcher, Dr. Jacob Thorsted Sørensen, shares his findings on the importance of Point of Care Troponin testing as a prehospital decision aid in patients with suspected ACS and/or at high risk of mortality.
In a lunch-break-friendly forty minutes, Dr. Sørensen takes us on a journey through the importance of decision aids in the prehospital setting, and how the high predictive value of POC Troponin can aid health professionals in improving triage and treatment for high-risk ACS patients. He explores the subject of implementing a new technology in this field, and his presentation is supported by real-world examples that he documented during studies in which all ambulances in the Central Denmark Region were equipped with a POC Troponin T device for use in suspected ACS cases.2,3
Please enjoy this webinar on this exciting topic. Thank you in advance for watching.
